Bulletin from the Annual General Meeting of CellaVision AB (publ) held on May 2, 2012
(Thomson Reuters ONE) -
The CellaVision Annual General Meeting (AGM) convened earlier today in Lund, May
2, 2012, and resolved upon the following:
* Payment of dividend in the amount of SEK 0.40 per share with 7 May 2012 as
record date, meaning that payment will is expected to be made on 10 May 2012
* Discharge from liability for the members of the Board of Directors and the
President and CEO
* Re-election of all members of the Board and the auditor
* Resolution on remuneration for the members of the Board and the auditor
More detailed information concerning the resolutions passed at the general
meeting of shareholders is available in Swedish only.
CEO Yvonne Mårtensson's address to the meeting is available via the link below.
For more information, please contact:
Lars Gatenbeck, Chairman of the Board, CellaVision AB.
Tel: +46 70 535 44 44. E-mail: lars.gatenbeck(at)lifemedical.se
Yvonne Mårtensson, CEO, CellaVision AB.
Tel: +46 708 33 77 82. E-mail: yvonne.martensson(at)cellavision.com
About CellaVision
CellaVision is an innovative, global medical technology company that develops
and sells best-in-class systems for the routine analysis of blood and other body
fluids. These analyses often provide critical results used in the diagnosis of a
variety of illnesses such as infection and cancer. CellaVision's products reduce
manual laboratory work, standardize results and support an efficient laboratory
workflow. The company has leading-edge expertise in digital image analysis,
artificial intelligence and automated microscopy. In 2011 sales were SEK 155
million and sales continue to increase, with a growth target of at least 15 %
per year over an economic cycle. CellaVision's registered office is in Lund and
the company has subsidiaries in the USA, Canada and Japan. The share is listed
on the Nasdaq, OMX Stockholm, Small Cap list. Read more at www.cellavision.com.
Publication
This information is disclosed by CellaVision AB (publ) pursuant to the
Securities Market Act and/or the Financial Instruments Trading Act. The
information was released for public disclosure on May 2, 2012 at 18.30.
CEO Yvonne Mårtensson's address to the meeting:
http://hugin.info/132164/R/1607953/510164.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: CellaVision AB via Thomson Reuters ONE
[HUG#1607953]
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 02.05.2012 - 12:31 Uhr
Sprache: Deutsch
News-ID 1109879
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
Lund
Phone:
Kategorie:
Business News
Anmerkungen:
Diese Pressemitteilung wurde bisher 57 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Bulletin from the Annual General Meeting of CellaVision AB (publ) held on May 2, 2012
"
steht unter der journalistisch-redaktionellen Verantwortung von
CellaVision AB (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
